Taissa Cherry
Kaiser Permanente
12 Papers
Taissa Cherry is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Treatment of nonsurgical refractory back pain with high-frequency spinal cord stimulation at 10 kHz: 12-month results of a pragmatic, multicenter, randomized controlled trial.
Leonardo Kapural,Jessica Jameson,Curtis Johnson,Daniel Kloster,Aaron K. Calodney,Peter Kosek,Julie G. Pilitsis,Markus A. Bendel,Erika A. Petersen,Chengyuan Md Wu,Taissa Cherry,Shivanand P. Lad,Cong Yu,Dawood Sayed,Johnathan H. Goree,Mark K. Lyons,Andrew M Sack,Diana Bruce,Frances Rubenstein,Rose Province-Azalde,David Caraway,Naresh P. Patel +21 more
- 01 Feb 2022
TL;DR: Important insights are provided into the durability of 10-kHz SCS therapy with respect to chronic refractory back pain, physical function, quality of life, and opioid use, informing the current clinical practice for pain management in patients with NSRBP.
34
Trigeminal and sphenopalatine ganglion stimulation for intractable craniofacial pain--case series and literature review
Arsani William,Tej D. Azad,Eliezer Brecher,Taissa Cherry,Ivan Bernstein,Diana Bruce,Stacey Rohrer,Zachary A. Smith,Mary William,Eric Sabelman,Gary Heit,Patrick Pezeshkian,Mark Sedrak +12 more
TL;DR: Refractory facial pain may respond positively to ganglionic forms of stimulation, and it appears safe and durable to implant electrodes in the pterygopalatine fossa via a lateral transpterygoid approach.
26
High-Frequency Spinal Cord Stimulation at 10 kHz for the Treatment of Nonsurgical Refractory Back Pain: Design of a Pragmatic, Multicenter, Randomized Controlled Trial.
Naresh P. Patel,Aaron K. Calodney,Leonardo Kapural,Rose Province-Azalde,Shivanand P. Lad,Julie G. Pilitsis,Chengyuan Wu,Taissa Cherry,Jeyakumar Subbaroyan,Bradford E. Gliner,David Caraway +10 more
TL;DR: Level 1 evidence does not yet exist showing the therapeutic benefit of SCS for NSRBP, so this condition is termed nonsurgical refractory back pain (NSRBP).
17
Durable responses at 24 months with high-frequency spinal cord stimulation for nonsurgical refractory back pain.
Jessica Jameson,Curtis Johnson,Daniel Kloster,Aaron K. Calodney,Peter Kosek,Julie Pilitsis,Markus Bendel,Erika A. Petersen,Chengyuan Wu,Taissa Cherry,Shivanand P. Lad,Cong Yu,Dawood Sayed,Johnathan H. Goree,Mark Lyons,Andrew M Sack,Diana Bruce,Manish Bharara,Rose Province-Azalde,David Caraway,Leonardo Kapural +20 more
- 01 Nov 2023
TL;DR: The addition of high-frequency SCS to CMM in patients with NSRBP offers profound improvements at 24 months in pain, function, quality of life, and reduced opioid use.
5
ID: 218207 10kHz Spinal Cord Stimulation for Non-Surgical Refractory Back Pain: Objective Functional Outcome to 24-Months
Leonardo Kapural,Jessica Jameson,Naresh D. Patel,Curtis Johnson,Daniel Kloster,Aaron K. Calodney,Peter Kosek,Julie G. Pilitsis,Markus A. Bendel,Erika A. Petersen,Chengyuan Md Wu,Taissa Cherry,Nandan Lad,Cong Yu,Dawood Sayed,Johnathan H. Goree,Michael J. Lyons,Andrew R. Sacks,Diana Bruce,Rose Province-Azalde,David Caraway +20 more
TL;DR: In this paper , spinal cord stimulation (SCS) is used to treat non-surgical refractory back pain (NSRBP) in patients who have failed conventional medical management (CMM).